Michele Ceribelli

5.6k total citations
43 papers, 1.4k citations indexed

About

Michele Ceribelli is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Michele Ceribelli has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Michele Ceribelli's work include Lymphoma Diagnosis and Treatment (10 papers), Protein Degradation and Inhibitors (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Michele Ceribelli is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Protein Degradation and Inhibitors (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Michele Ceribelli collaborates with scholars based in United States, Italy and Japan. Michele Ceribelli's co-authors include Louis M. Staudt, Roland Schmitz, Roberto Mantovani, George W. Wright, Stefania Pittaluga, Lixin Rui, Boris Reizis, Craig J. Thomas, M Viganò and Hiyaa S. Ghosh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Michele Ceribelli

40 papers receiving 1.4k citations

Peers

Michele Ceribelli

IMMUN

ONCOL

PFM

Alexander L. Kovalchuk United States

Kun-Sang Chang United States

Ivo J. Huijbers Netherlands

Julia K. Pagan United States

Samuel Y. Ng United States

Fumihiko Okumura Japan

Lin Tai Australia

Anthony C. Liang United States

Jacqueline E. Payton United States

Brenda O’Connell United States

Alexander L. Kovalchuk United States

Michele Ceribelli

616 ×0.8

398 ×1.0

IMMUN

291 ×0.7

ONCOL

157 ×0.6

PFM

108 ×0.6

Citations per year, relative to Michele Ceribelli Michele Ceribelli (= 1×) peers Alexander L. Kovalchuk

Countries citing papers authored by Michele Ceribelli

Since Specialization

Citations

This map shows the geographic impact of Michele Ceribelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Ceribelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Ceribelli more than expected).

Fields of papers citing papers by Michele Ceribelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Ceribelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Ceribelli. The network helps show where Michele Ceribelli may publish in the future.

Co-authorship network of co-authors of Michele Ceribelli

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Ceribelli. A scholar is included among the top collaborators of Michele Ceribelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Ceribelli. Michele Ceribelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schmidt, Keith T., Kelli M. Wilson, Crystal McKnight, et al.. (2025). Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7–Expressing CRPC Models. Cancer Research Communications. 5(8). 1396–1408.

Hassan, Aishlin, Kwangmin Choi, Courtnee Clough, et al.. (2025). Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization. Leukemia. 39(9). 2163–2173. 2 indexed citations

Birdwell, Christine, Warren Fiskus, Christopher P. Mill, et al.. (2025). BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML. Leukemia. 40(2). 304–313.

Zhang, Xiaohu, Patricia Alfonso, Patrick J. Morris, et al.. (2025). An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors. ACS Pharmacology & Translational Science. 8(12). 4312–4325.

Bernardini, Andrea, Michele Ceribelli, Giacomo Donati, et al.. (2024). Genomic binding of NF-Y in mouse and human cells. Genomics. 116(5). 110895–110895. 3 indexed citations

Murai, Junko, Michele Ceribelli, Haiqing Fu, et al.. (2023). Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication. Molecular Cancer Therapeutics. 22(8). 985–995. 5 indexed citations

Chory, Emma J., Meng Wang, Michele Ceribelli, et al.. (2023). High-throughput approaches to uncover synergistic drug combinations in leukemia. SLAS DISCOVERY. 28(4). 193–201. 4 indexed citations

Morris, Patrick J., et al.. (2023). Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma. Pharmaceuticals. 16(12). 1635–1635. 8 indexed citations

Reinhold, William C., Kelli M. Wilson, Fathi Elloumi, et al.. (2023). CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations. Cancer Research. 83(12). 1941–1952. 12 indexed citations

10.

Morse, David B., Aleksandra M. Michalowski, Michele Ceribelli, et al.. (2023). Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics. Cell Systems. 14(6). 464–481.e7. 8 indexed citations

11.

Kim, Yong, Robert G. Hawley, Teresa S. Hawley, et al.. (2023). Abstract 3538: Endogenous HiBiT-tagging of PAX3-FOXO1 identifies potent suppressors of PAX3-FOXO1 protein levels by high-throughput screening. Cancer Research. 83(7_Supplement). 3538–3538. 1 indexed citations

12.

Bello, Thomas R., Marina Chan, Martin Golkowski, et al.. (2021). KiRNet: Kinase-centered network propagation of pharmacological screen results. Cell Reports Methods. 1(2). 100007–100007. 10 indexed citations

13.

Wiegard, Anika, Donald P. Cameron, Michele Ceribelli, et al.. (2021). Topoisomerase 1 activity during mitotic transcription favors the transition from mitosis to G1. Molecular Cell. 81(24). 5007–5024.e9. 14 indexed citations

14.

Heske, Christine M., Mindy I. Davis, Joshua T. Baumgart, et al.. (2017). Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma. Clinical Cancer Research. 23(23). 7301–7311. 50 indexed citations

15.

Grajkowska, Lucja T., Michele Ceribelli, Colleen M. Lau, et al.. (2016). Isoform-Specific Expression and Feedback Regulation of E Protein TCF4 Control Dendritic Cell Lineage Specification. Immunity. 46(1). 65–77. 79 indexed citations

16.

Bunin, Anna, Vanja Sisirak, Hiyaa S. Ghosh, et al.. (2015). Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells. Immunity. 43(2). 277–288. 43 indexed citations

17.

Schmitz, Roland, et al.. (2014). Oncogenic Mechanisms in Burkitt Lymphoma. Cold Spring Harbor Perspectives in Medicine. 4(2). a014282–a014282. 157 indexed citations

18.

Donati, Giacomo, Raffaella Gatta, Diletta Dolfini, et al.. (2008). An NF-Y-Dependent Switch of Positive and Negative Histone Methyl Marks on CCAAT Promoters. PLoS ONE. 3(4). e2066–e2066. 26 indexed citations

19.

Ceribelli, Michele, Myriam Alcalay, M Viganò, & Roberto Mantovani. (2006). Repression of New p53 Targets Revealed by ChIP on Chip Experiments. Cell Cycle. 5(10). 1102–1110. 42 indexed citations

20.

Minuzzo, Mario, et al.. (2005). Selective Effects of the Anticancer Drug Yondelis (ET-743) on Cell-Cycle Promoters. Molecular Pharmacology. 68(5). 1496–1503. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact